Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-756991x
Shrank
—
—
—
—
1 Year
Score—
Net Growth-756991x
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
5 Years
—
-6529646x
40%
—
—
Never
—
5 Years
Score—
Net Growth-6529646x
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
PharmaCyte Biotech Inc fundamental performance
Across PharmaCyte Biotech Inc's full reported history, from 2011 to 2026, net income went from -$ 1M to -$ 23.20T. Revenue increased in 0% of the years measured; net income in 60%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 0.55 | — |
1 Year2025-08-13 | $ 0.85 | -35.29% |
5 Years2021-08-13 | $ 3.27 | -83.18% |
10 Years2016-08-12 | $ 53.25 | -98.97% |
20 Years2006-08-11 | $ 390.02 | -99.86% |
All Time2010-09-17 | $ 9.90 | -94.44% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2010-09-17 |
|---|---|---|---|---|---|---|
| Price | $ 0.55 | $ 0.85 | $ 3.27 | $ 53.25 | $ 390.02 | $ 9.90 |
| Return | — | -35.29% | -83.18% | -98.97% | -99.86% | -94.44% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | -$ 23.20T | $ 18.85T | |
| 2025 | $ 0.00 | $ 30M | $ 15M |
| 2024 | $ 0.00 | $ 333.76K | $ 50M |
| 2023 | $ 0.00 | -$ 4M | $ 68M |
| 2022 | $ 0.00 | -$ 4M | $ 85M |
| 2021 | $ 0.00 | -$ 3M | $ 2M |
| 2020 | $ 0.00 | -$ 3M | $ 2M |
| 2019 | $ 0.00 | -$ 4M | $ 515.25K |
| 2018 | $ 0.00 | -$ 6M | $ 1M |
| 2017 | $ 0.00 | -$ 4M | $ 3M |
| 2016 | $ 0.00 | -$ 6M | $ 1M |
| 2015 | $ 0.00 | -$ 10M | $ 2M |
| 2014 | $ 0.00 | -$ 27M | $ 3M |
| 2013 | $ 12.16K | -$ 1M | $ 199.3K |
| 2012 | $ 66.56K | -$ 1M | $ 15.72K |
| 2011 | $ 126K | -$ 1M | $ 57.2K |
Explore beyond PMCB
You're looking at PharmaCyte Biotech Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
